Literature DB >> 20671022

Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome.

Lydia G Schipper1, Laura T C van Hulst, Richard Grol, Piet L C M van Riel, Marlies E J L Hulscher, Jaap Fransen.   

Abstract

OBJECTIVES: Tight control studies including regular assessments of disease activity have shown that this approach has beneficial effects on disease activity, disability and joint damage in treating RA patients. Some of these studies included tight control with protocolized treatment, while others applied tight control without protocolized treatment. The aim of this study was to compare the effects of tight control with usual care and to compare the effects of tight control studies with and without protocolized treatment adjustments.
METHODS: A systematic literature search was performed to identify clinical trials in RA that evaluated tight control strategies in comparison with usual care. Two types of study were compared: (i) those using disease activity monitoring with protocolized treatment adjustments, and (ii) those using disease activity monitoring without protocolized treatment adjustments. The databases PubMed and Cochrane were searched from 1995 up to 2009. Primary outcome measure was the mean change in the 28-joint DAS (DAS-28), which was used in a random-effects meta-analysis.
RESULTS: Six controlled trials regarding tight control in RA patients were included in the meta-analysis. In all trials, patients treated in the tight control arms had significantly higher DAS-28 responses than patients treated according to usual care [weighted mean difference (WMD) = 0.59, P < 0.001]. Moreover, tight control was significantly more effective (P < 0.001) by means of protocolized treatment adjustments (WMD = 0.97) compared with non-protocolized monitoring of disease activity (WMD = 0.25).
CONCLUSION: Tight control in RA resulted in significantly better clinical outcomes than usual care. It is suggested but not proved that tight control with protocolized treatment adjustments is more beneficial than if no such protocol is used.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20671022     DOI: 10.1093/rheumatology/keq195

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  38 in total

1.  Impact of tight control strategy on rheumatoid arthritis in Sarawak.

Authors:  Cheng Lay Teh; Jin Shyan Wong
Journal:  Clin Rheumatol       Date:  2010-10-01       Impact factor: 2.980

2.  Subjective numeracy and preference to stay with the status quo.

Authors:  Liana Fraenkel; Meaghan Cunningham; Ellen Peters
Journal:  Med Decis Making       Date:  2014-04-23       Impact factor: 2.583

Review 3.  Remission-induction therapies for early rheumatoid arthritis: evidence to date and clinical implications.

Authors:  Francisco Espinoza; Sylvie Fabre; Yves-Marie Pers
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-06-13       Impact factor: 5.346

4.  [Therapy of rheumatoid arthritis with methotrexate. Claims data analysis of treatment patterns].

Authors:  J Zeidler; H Zeidler; J-M Graf von der Schulenburg
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

5.  Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: results of a maximum difference scaling experiment.

Authors:  L T C van Hulst; W Kievit; R van Bommel; P L C M van Riel; L Fraenkel
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-10       Impact factor: 4.794

6.  Quality of care of rural rheumatoid arthritis patients in Austria.

Authors:  Rudolf Puchner; Hans Peter Brezinschek; Manfred Herold; Thomas Nothnagl; Andrea Studnicka-Benke; Josef Fritz; Burkhard F Leeb
Journal:  Wien Klin Wochenschr       Date:  2014-03-28       Impact factor: 1.704

7.  Cost-effectiveness of clinical remission by treat to target strategy in established rheumatoid arthritis: results of the CREATE registry.

Authors:  M Cárdenas; S de la Fuente; M C Castro-Villegas; M Romero-Gómez; D Ruiz-Vílchez; J Calvo-Gutiérrez; A Escudero-Contreras; J R Del Prado; E Collantes-Estévez; P Font
Journal:  Rheumatol Int       Date:  2016-10-24       Impact factor: 2.631

8.  Treat-to-target concept implementation for evaluating rheumatoid arthritis patients in daily practice.

Authors:  Tal Gazitt; Shirley Oren; Tatiana Reitblat; Merav Lidar; Alexandra Balbir Gurman; Itzhak Rosner; Nimer Halabe; Joy Feld; Sameer Kassem; Idit Lavi; Ori Elkayam; Devy Zisman
Journal:  Eur J Rheumatol       Date:  2019-05-20

9.  Barriers to treatment adjustment within a treat to target strategy in rheumatoid arthritis: a secondary analysis of the TRACTION trial.

Authors:  Agnes Zak; Cassandra Corrigan; Zhi Yu; Asaf Bitton; Liana Fraenkel; Leslie Harrold; Josef S Smolen; Daniel H Solomon
Journal:  Rheumatology (Oxford)       Date:  2018-11-01       Impact factor: 7.580

Review 10.  Treat-to-target in spondyloarthritis: implications for clinical trial designs.

Authors:  James Cheng-Chung Wei
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.